Insmed announces positive results from Phase III arise study of ARIKAYCE
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
The cognitively operated system is a mother patent invention, first launched in India
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
Propranolol LA is a generic equivalent of Inderal LA
Subscribe To Our Newsletter & Stay Updated